Evidence map›Paper›PMID 40386555›Full record

ArticleFrontiers in oncology2025

Key stakeholders' experiences, knowledge and perspectives regarding care quality for breast cancer in South-West Nigeria.

Adewumi Alabi, Victoria Ainsworth, Abdulrazzaq Lawal, Darya Kizub, Jennifer Chin, Carly Woodmark, Olubukola Omidiji, Bolanle Adegboyega, Anthonia Sowunmi, Adedoyin Ogunyemi and 3 more

Abstract read
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Adewumi AlabiDepartment of Radiation Biology, Radiodiagnosis and Radiotherapy, College of Medicine, University of Lagos, Lagos, Nigeria.
Victoria AinsworthDepartment of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University, Baltimore, MD, United States.
Abdulrazzaq LawalDepartment of Surgery, College of Medicine, University of Lagos, Lagos, Nigeria.
Darya KizubDepartment of Breast Medical Oncology, Division of Cancer Medicine, MD Anderson Cancer Center, Houston, TX, United States.
Jennifer ChinDepartment of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University, Baltimore, MD, United States.
Carly WoodmarkProject Management, Fred Hutch Cancer Centre, Seattle, WA, United States.
Olubukola OmidijiDepartment of Radiation Biology, Radiodiagnosis and Radiotherapy, College of Medicine, University of Lagos, Lagos, Nigeria.
Bolanle AdegboyegaDepartment of Radiation Biology, Radiodiagnosis and Radiotherapy, College of Medicine, University of Lagos, Lagos, Nigeria.
Anthonia SowunmiDepartment of Radiation Biology, Radiodiagnosis and Radiotherapy, College of Medicine, University of Lagos, Lagos, Nigeria.
Adedoyin OgunyemiDepartment of Community Medicine, College of Medicine, University of Lagos, Lagos, Nigeria.
William SwansonDepartment of Radiation Oncology, Weill Cornell Medicine, New York, NY, United States.
Adedayo JosephDepartment of Radiation Biology, Radiodiagnosis and Radiotherapy, College of Medicine, University of Lagos, Lagos, Nigeria.
Wilfred NgwaDepartment of Surgery, College of Medicine, University of Lagos, Lagos, Nigeria.

Funding

Biomaterial Drones for Image-Guided Drug Delivery during radiotherapyR01CA239042 · NCI · JOHNS HOPKINS UNIVERSITY · PI NGWA, WILFRED · 2019 to 2023
$3.2M
NCI NIH HHS R01 CA239042
6 · The paper itself

Abstract

The landscape of breast cancer care in Nigeria is complex, with various structural and individual barriers impacting patient care. Breast cancer (BC) is the most common cancer and a leading cause of cancer deaths among women worldwide. In Africa, the cancer burden is expected to rise significantly, with projections estimating an increase of 50% by 2050. Rising incidence rates and barriers to care contribute to a healthcare crisis, leading to late-stage presentation and high mortality rates for women with breast cancer in Nigeria. Quality healthcare must be patient-centered, involving stakeholders - patients, clinical and community partners, and other healthcare stakeholders to achieve a desired outcome. Understanding the cancer journey from different perspectives allows for targeted approaches for increasing access to quality healthcare as well as reducing morbidity and mortality rates. To address this, healthcare provider perspectives about breast cancer care were compared with the lived experiences of breast cancer patients to emphasize the need to increase access and quality of care. A mixed method study was conducted in 2 phases: Phase I: 3 Focus group discussions (FGDs) with breast cancer patients and their care givers were conducted at the NSIA-LUTH Cancer Centre in Lagos, Nigeria. Phase II: A pre and post-survey of a continuing medical education course focused on breast cancer was delivered to healthcare providers in southwest Nigeria. Survey responses regarding causes for delays and barriers to care indicated financial strain, fear, and alternative treatments as the largest hurdles, coinciding with patient testimony from the FGD. Fear of mastectomy was a perceived barrier to care for 90% of healthcare providers while 87% and 86% of providers perceived seeking spiritual and herbal treatments as the largest delays of care. Despite this, a significant number of focus group participants (39%) presented within the first month of noticing a breast symptom to a proper healthcare provider. Data from our study reports that 70% of patients receive help from family to fund treatment highlighting why cancer can be a poverty trap for families and the need for universal health insurance. Half of the focus group participants had a positive interaction with their doctors, with the rest reporting neutral (19%) or even negative (31%) interactions. Our study also reports 42% of healthcare providers feeling only "somewhat" qualified to deal with breast cancer, highlighting the significant need for more education, with a further 14% feeling neutral or negative about their qualification, a potential contributing factor in negative interactions recalled by patients. Knowledge increase was consistent for best practice diagnostic modalities among healthcare providers (p < 0.05). At the same time, items related to symptoms and risks of breast cancer had inconsistent knowledge increases, indicating why further courses like these should be pursued. With the success of the course and the inspiration of breast cancer survivors, a proposed expansion into community awareness is discussed along with enlisting local practitioners in the fight against breast cancer in hopes of lowering the barriers to and delays of care in Nigeria.

Indexed as

breast cancercontinuing medical education (CME)delay of careglobal healthNigeriapatient experiences

Identifiers

PMID40386555
PMCPMC12081249

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.